WHITEHAWK THERAPEUTICS, INC. Accumulated Other Comprehensive Income
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Accumulated Other Comprehensive Income of -$63.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$63.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$15.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $120.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $139.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$63.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$15.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $120.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $139.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $39.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$27.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$8.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $27.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$16.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$44.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$32.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$115.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$99.00K 10-Q · filed 2022-11-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |